Microbix Biosystems Inc (MBXBF) reports robust growth in antigen and CAPS sales, improved profitability metrics, and strategic progress in its Kinlytic program despite ongoing net losses.

Amidst the backdrop of steady interest rates and a mixed economic outlook in Canada, investors are turning their attention to potential opportunities in the stock market. Penny stocks, though often associated with speculative trading, remain an intriguing area for those seeking growth potential within smaller or newer companies. When these stocks are supported by strong financials, they can offer unique chances for significant returns.

Microbix Biosystems (MBX.TO), a life sciences innovator, manufacturer, and exporter, announced Tuesd

Despite a revenue decline, Microbix Biosystems Inc (MBXBF) focuses on strategic investments and product expansion to drive future growth.

Microbix Biosystems (MBX.TO) on Thursday reported a swing to a fourth-quarter loss as revenue plunge

Microbix Biosystems (MBX.TO), a life sciences innovator, manufacturer, and exporter, on Wednesday ad

As the Canadian market navigates through a period of uncertainty, with central banks offering limited guidance on future policy directions, investors are keeping a close eye on economic indicators to gauge potential interest rate cuts. In such volatile times, penny stocks—despite their somewhat outdated moniker—remain an intriguing investment area due to their affordability and growth potential. These smaller or newer companies can offer significant returns when backed by strong financials,...